Pulmonary edema

53,613views

Pulmonary edema

RHS

RHS

Viral structure and functions
Rhinovirus
Adenovirus
Influenza virus
Human parainfluenza viruses
Respiratory syncytial virus
Staphylococcus aureus
Streptococcus viridans
Streptococcus pyogenes (Group A Strep)
Streptococcus pneumoniae
Corynebacterium diphtheriae (Diphtheria)
Enterococcus
Upper respiratory tract infection
Allergic rhinitis
Bacillus anthracis (Anthrax)
Nocardia
Enterobacter
Yersinia enterocolitica
Pseudomonas aeruginosa
Klebsiella pneumoniae
Legionella pneumophila (Legionnaires disease and Pontiac fever)
Bacteroides fragilis
Yersinia pestis (Plague)
Moraxella catarrhalis
Francisella tularensis (Tularemia)
Bordetella pertussis (Whooping cough)
Haemophilus influenzae
Pasteurella multocida
Mycobacterium tuberculosis (Tuberculosis)
Mycobacterium leprae
Mycobacterium avium complex (NORD)
Mycoplasma pneumoniae
Chlamydia pneumoniae
Coxiella burnetii (Q fever)
Epstein-Barr virus (Infectious mononucleosis)
Human herpesvirus 6 (Roseola)
Human herpesvirus 8 (Kaposi sarcoma)
Parvovirus B19
Mumps virus
Measles virus
Zika virus
Rubella virus
Candida
Plasmodium species (Malaria)
Asthma: Clinical
Pneumonia
Pneumonia: Pathology review
Respiratory distress syndrome: Pathology review
Restrictive lung diseases
Restrictive lung diseases: Pathology review
Sarcoidosis
Hypersensitivity pneumonitis
Obstructive lung diseases: Pathology review
Tuberculosis: Pathology review
Type IV hypersensitivity
Bartonella henselae (Cat-scratch disease and Bacillary angiomatosis)
Sinusitis
Laryngitis
Retropharyngeal and peritonsillar abscesses
Bacterial epiglottitis
Congenital pulmonary airway malformation
Acute respiratory distress syndrome
Emphysema
Asthma
Bronchiectasis
Cystic fibrosis
Alpha 1-antitrypsin deficiency
Chronic bronchitis
Idiopathic pulmonary fibrosis
Lung cancer
Superior vena cava syndrome
Pancoast tumor
Pneumothorax
Mesothelioma
Pleural effusion
Pulmonary embolism
Pulmonary hypertension
Pulmonary edema
Cystic fibrosis: Pathology review
Deep vein thrombosis and pulmonary embolism: Pathology review
Pleural effusion, pneumothorax, hemothorax and atelectasis: Pathology review
Apnea, hypoventilation and pulmonary hypertension: Pathology review
Lung cancer and mesothelioma: Pathology review
Iron deficiency anemia
Beta-thalassemia
Alpha-thalassemia
Sideroblastic anemia
Anemia of chronic disease
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Autoimmune hemolytic anemia
Sickle cell disease (NORD)
Aplastic anemia
Folate (Vitamin B9) deficiency
Vitamin B12 deficiency
Acute intermittent porphyria
Hemophilia
Hemolytic-uremic syndrome
Thrombotic thrombocytopenic purpura
Immune thrombocytopenia
Von Willebrand disease
Disseminated intravascular coagulation
Heparin-induced thrombocytopenia
Hodgkin lymphoma
Non-Hodgkin lymphoma
Chronic leukemia
Acute leukemia
Myelodysplastic syndromes
Polycythemia vera (NORD)
Myelofibrosis (NORD)
Essential thrombocythemia (NORD)
Mastocytosis (NORD)
Microcytic anemia: Pathology review
Non-hemolytic normocytic anemia: Pathology review
Intrinsic hemolytic normocytic anemia: Pathology review
Extrinsic hemolytic normocytic anemia: Pathology review
Macrocytic anemia: Pathology review
Heme synthesis disorders: Pathology review
Coagulation disorders: Pathology review
Platelet disorders: Pathology review
Mixed platelet and coagulation disorders: Pathology review
Thrombosis syndromes (hypercoagulability): Pathology review
Lymphomas: Pathology review
Leukemias: Pathology review
Plasma cell disorders: Pathology review
Myeloproliferative disorders: Pathology review
Bronchioles and alveoli histology
Trachea and bronchi histology
Lung volumes and capacities
Alveolar surface tension and surfactant
Ventilation
Zones of pulmonary blood flow
Regulation of pulmonary blood flow
Pulmonary shunts
Ventilation-perfusion ratios and V/Q mismatch
Airflow, pressure, and resistance
Gas exchange in the lungs, blood and tissues
Diffusion-limited and perfusion-limited gas exchange
Blood histology
Blood components
Erythropoietin
Ribonucleotide reductase inhibitors
Topoisomerase inhibitors
Platinum containing medications
Anti-tumor antibiotics
Microtubule inhibitors
DNA alkylating medications
Monoclonal antibodies
Antimetabolites for cancer treatment
Antimalarials

Transcript

Watch video only

Pulmonary edema refers to the buildup of fluid in the lungs including the airways like the alveoli - which are the tiny air sacs - as well as in the interstitium, which is the lung tissue that’s sandwiched between the alveoli and the capillaries.

This space is mostly full of proteins, and when it starts filling up with fluid, it can make it hard for oxygen to cross over from the alveoli into the capillary, leaving the body hypoxic - or deprived of oxygen.

To understand pulmonary edema, let’s first talk about the three main factors that determine how fluid moves between the capillaries and interstitial fluid, which are the hydrostatic pressure, oncotic pressure and capillary permeability.

Hydrostatic pressure refers to the pressure felt by fluid in a confined space, pushing the fluid out of that space.

In the interstitial space, it’s the same thing as the blood pressure in the pulmonary capillaries, and because the pulmonary circulation is a low pressure system, the hydrostatic pressure is pretty low. But it’s still higher than the hydrostatic pressure exerted by the interstitial fluid of the lungs - which is almost zero.

So, to be clear, if hydrostatic pressure was the only factor involved, a lot of fluid would be continuously leaking out of the pulmonary capillaries into the lung’s interstitial space.

The next factor, though, is oncotic pressure; which is a type of osmotic pressure exerted by cells and proteins that can’t cross the capillary membrane and therefore tend to attract fluid.

The oncotic pressure is higher in the pulmonary capillaries than in the interstitial fluid, so it opposes the hydrostatic pressure.

Finally, there’s capillary permeability or leakiness which affects how easily fluid is actually able to get through.

When taking these three factors together, the net result is that a very small amount of fluid leaks into the interstitial space, and that fluid is normally whisked away by the lymphatic channels in the lungs, which keeps the lungs free of excess fluid.

Now, the underlying cause of pulmonary edema can be cardiogenic - meaning that it develops as a result of a heart disease, or can be non-cardiogenic which typically involves damage to the pulmonary capillaries or alveoli.

The most common cardiogenic cause is left-sided heart-failure, and in left-sided heart failure, the left ventricle becomes unhealthy and can’t pump effectively, which means that blood starts to backup in the left atrium, and then the pulmonary veins and pulmonary capillaries.

The extra blood in the pulmonary capillaries causes pulmonary hypertension - which is an increase in the hydrostatic pressure of the pulmonary blood vessels, and this pushes more fluid into the interstitial space of the lungs which leads to pulmonary edema.

Another cardiogenic cause is severe systemic hypertension - specifically a blood pressure that is greater than 180 systolic or 110 diastolic. In this situation, the left ventricle is healthy but simply can’t effectively pump blood in a system with such high afterload - in other words, under conditions with such high systemic pressures.

Once again, blood starts to back up in the left atrium, pulmonary veins, and pulmonary capillaries, ultimately leading to pulmonary hypertension and pulmonary edema.

Noncardiogenic causes of pulmonary edema include things like pulmonary infections, inhalation of toxic substances, and trauma to the chest.

All of these can cause direct injury to the alveoli, and when this happens there is usually an inflammatory process that makes nearby capillaries more permeable. As a result, proteins and fluid enter the interstitial space.

Another cause is sepsis, and the key difference is that in sepsis the inflammatory process happens throughout the body rather than just in the lungs, so in addition to pulmonary edema, sepsis can cause extra fluid in the interstitial space of tissues throughout the body.

Another category of non-cardiogenic causes is having low oncotic pressure.

Key Takeaways

Pulmonary edema is a condition in which fluid accumulates in the lungs, making it difficult for oxygen to pass through the alveoli and into the bloodstream. It is often due to the left ventricular heart failure to adequately remove blood from the pulmonary circulation, which is known as cardiogenic pulmonary edema. It can also be due to an injury to the lung parenchyma or vasculature of the lung - known as noncardiogenic pulmonary edema.

If not treated, pulmonary edema can lead to respiratory failure or cardiac arrest due to hypoxia. Treatment focuses on improving respiratory function, treating the underlying cause, and preventing and avoiding further damage to the lung.

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  3. "Pathophysiology of Disease: An Introduction to Clinical Medicine 8E" McGraw-Hill Education / Medical (2018)
  4. "CURRENT Medical Diagnosis and Treatment 2020" McGraw-Hill Education / Medical (2019)
  5. "Acute Pulmonary Edema" New England Journal of Medicine (2005)
  6. "Causes of mortality in patients with the adult respiratory distress syndrome" PubMed
  7. "Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries" JAMA (2016)